Skip to content
lifestyle.toptraveltrends.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Orchestra BioMed Holdings, Inc.
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 12, 2026
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
May 12, 2026
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
May 6, 2026
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
April 30, 2026
←
Previous Page
1
2